These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2330490)
21. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319 [TBL] [Abstract][Full Text] [Related]
22. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis. Sorensen KN; Sobel RA; Clemons KV; Pappagianis D; Stevens DA; Williams PL Antimicrob Agents Chemother; 2000 Jun; 44(6):1512-7. PubMed ID: 10817701 [TBL] [Abstract][Full Text] [Related]
23. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. Park DW; Sohn JW; Cheong HJ; Kim WJ; Kim MJ; Kim JH; Shin C BMC Infect Dis; 2006 Feb; 6():26. PubMed ID: 16480497 [TBL] [Abstract][Full Text] [Related]
24. Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis. Thompson GR; Lunetta JM; Johnson SM; Taylor S; Bays D; Cohen SH; Pappagianis D Clin Infect Dis; 2011 Sep; 53(6):e20-4. PubMed ID: 21865185 [TBL] [Abstract][Full Text] [Related]
25. Ketoconazole treatment of coccidioidal meningitis. Graybill JR; Stevens DA; Galgiani JN; Sugar AM; Craven PC; Gregg C; Huppert M; Cloud G; Dismukes WE Ann N Y Acad Sci; 1988; 544():488-96. PubMed ID: 3214090 [TBL] [Abstract][Full Text] [Related]
26. Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents. Robinson PA; Knirsch AK; Joseph JA Rev Infect Dis; 1990; 12 Suppl 3():S349-63. PubMed ID: 2330489 [TBL] [Abstract][Full Text] [Related]
27. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. Diaz M; Negroni R; Montero-Gei F; Castro LG; Sampaio SA; Borelli D; Restrepo A; Franco L; Bran JL; Arathoon EG Clin Infect Dis; 1992 Mar; 14 Suppl 1():S68-76. PubMed ID: 1562698 [TBL] [Abstract][Full Text] [Related]
28. Imidazole therapy of coccidioidal meningitis in children. Shehab ZM; Britton H; Dunn JH Pediatr Infect Dis J; 1988 Jan; 7(1):40-4. PubMed ID: 3340457 [TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha and interleukin-1 beta in cerebrospinal fluid of patients with coccidioidal meningitis during therapy with fluconazole. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Ampel NM; Ahmann DR; Delgado KL; Galgiani JN; Cloud GA J Infect Dis; 1995 Jun; 171(6):1675-8. PubMed ID: 7769317 [TBL] [Abstract][Full Text] [Related]
30. Infection of an arterial prosthesis as the presenting manifestation of disseminated coccidioidomycosis: control of disease with fluconazole. Schwartz DN; Fihn SD; Miller RA Clin Infect Dis; 1993 Apr; 16(4):486-8. PubMed ID: 8513052 [TBL] [Abstract][Full Text] [Related]
31. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Stern JJ; Hartman BJ; Sharkey P; Rowland V; Squires KE; Murray HW; Graybill JR Am J Med; 1988 Oct; 85(4):477-80. PubMed ID: 2845778 [TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid antibodies detected by ELISA against a 33-kDa antigen from spherules of Coccidioides immitis in patients with coccidioidal meningitis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Galgiani JN; Peng T; Lewis ML; Cloud GA; Pappagianis D J Infect Dis; 1996 Feb; 173(2):499-502. PubMed ID: 8568322 [TBL] [Abstract][Full Text] [Related]
38. Biofilm on ventriculo-peritoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis. Davis LE; Cook G; Costerton JW Emerg Infect Dis; 2002 Apr; 8(4):376-9. PubMed ID: 11971770 [TBL] [Abstract][Full Text] [Related]